AMGEN Inc

NASDAQ: AMGN
$270.00
+$3.55 (+1.3%)
Closing price April 11, 2024
Amgen Inc. is a biotechnology pioneer focused on developing and delivering innovative human therapeutics. Its portfolio includes treatments for serious illnesses such as rheumatoid arthritis, psoriasis, osteoporosis, and various types of cancer. Among its well-known products are Enbrel, Otezla, Prolia, and Repatha. Amgen also collaborates with other pharmaceutical giants to enhance its product offerings, demonstrating a commitment to improving patient health globally. Founded in 1980, Amgen has grown to serve healthcare providers and patients worldwide from its headquarters in Thousand Oaks, California.
Wednesday's top analyst upgrades and downgrades included Amgen, Canadian Pacific Kansas City, Carvana, Coinbase Global, Etsy, First Horizon, GE Healthcare Technologies, Gilead Sciences, Home Depot,...
With more banks failing and interest rates still rising, it may be time to take profits on the mega-cap winners and move to safer old-school stocks that can survive an economic downturn. These five...
With a recession likely on the way, health care is the place to be in 2023 for long-term investors looking for growth and income. These seven industry leaders offer solid total return potential in a...
Thursday's top analyst upgrades and downgrades included Amgen, Arista Networks, Bloom Energy, ConocoPhillips, Fastenal, Livent, On Holding, Palo Alto Networks, SLM, UnitedHealth, Vici Properties and...
With the second quarter now underway, these seven top dividend-paying Goldman Sachs stock picks make sense for growth and income investors who are looking for stocks that are still offering...
Given that the Nasdaq has only twice had two down years in a row, the five highest-yielding stocks in the index offer a contrarian angle for 2023 for growth and income investors looking for a way...
Tuesday's top analyst upgrades and downgrades included Ally Financial, Amgen, Baidu, Bilibili, Bill.com, Coinbase Global, Eli Lilly, GE Healthcare Technologies, JPMorgan Chase, Merck, Moderna,...
Tuesday's top analyst upgrades and downgrades included Amgen, Caterpillar, CF Industries, Coinbase Global, Fastly, Match, Newmont, Okta, Progressive, Toast, Under Armour, Walt Disney and Zim...
Tuesday's top analyst upgrades and downgrades included Amgen, Archer Daniels Midland, Boeing, Dow, LyondellBasell Industries, Netflix, Splunk, Spotify Technology, T-Mobile, Vale and Walmart.
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Amazon.com, Amgen, Corning, Edison International, Electronic Arts, Foot Locker, General Mills, Mattel, NXP...
Nobody ever went broke playing it safe in times of stress. These six high-conviction stock picks with some of the biggest dividends are safer ideas for nervous investors concerned about the economy...
Now that the last trading session of 2022 is behind us, here's the final ranking of 2023's Dogs of the Dow.
Investing in high-yielding Dow stocks at the end of the year is a strategy that has been around for a while. Here is a look at the new edition of the Dogs of the Dow.
After a horrific year in the markets, Jefferies has made some big changes to its Franchise Picks list of top stocks. These eight outstanding additions to the list have plenty of upside potential and...
The futures are trading lower as we start the Thanksgiving holiday-shortened trading week. The stock market is closed on the big turkey day, and will also shutter  early at 1 pm EST on Black Friday....